Valerian: Practical management of adverse effects and drug interactions

Canadian Pharmacists Journal

Volumn 139, Issue 3, 2006, Pages 39-41

  Cramer, Kristie ^a   Charrois, Theresa L ^a   Vohra, Sunita ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CARE Program   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; MELISSA OFFICINALIS EXTRACT; PLACEBO; VALERIAN; WARFARIN;

ANXIETY DISORDER; CLINICAL TRIAL; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG EFFECT; DRUG POTENTIATION; DRUG SAFETY; EXCITABILITY; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; MAXIMUM TOLERATED DOSE; META ANALYSIS; REVIEW; SIDE EFFECT; STOMACH DISCOMFORT; SYSTEMATIC REVIEW; UNSTEADINESS; VALERIANA OFFICINALIS; WORKING MEMORY;

EID: 33745913626     PISSN: 17151635     EISSN: None     Source Type: Journal    
DOI: 10.1177/171516350613900307     Document Type: Review

References (17)

1. Boon H, Smith M. The complete natural medicine guide to the 50 most common medicinal herbs. 2nd edition. Toronto, Ontario: Robert Rose; 2004.
2. Natural Standard Monograph. Valerian (Valeriana officinalis L.). 2006. Available: www.naturalstandard.com. (accessed March 2006).
3. Health Canada. Valerian. January 2004. Available: www.hc-sc.gc.ca/dhp- mps/prodnatur/applications/licen-prod/mono-graph/mono_valerian_e.html (accessed February 28,2006).
4. Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 2000;1:91-9.
5. Selim L, Westlake K, Boon H. Valerian. Available: www.camline.ca/ professionalreview/pr.php?NHPID=28 (accessed March 25, 2006).
6. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
7. Andreatini R, Sarori V, Seabra MLV, Leite JR. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res 2002;16:650-4.
8. Kennedy DO, Little W, Haskell CF, Scholey AB. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res 2006;20:96-102.
9. Chandler F, editor. Herbs: everyday reference for health professionals. Ottawa: Canadian Pharmacists Association and the Canadian Medical Association; 2000.
10. Kuhlmann J, Berger W, Podzuweit H, Schmidt U. The influence of valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry 1999;32:235-41.
11. Diaper A, Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. PhytotherRes 2004;18:831-6.
12. Plushner SL. Valerian: Valeriana officinalis. Am J Health Syst Pharm 2000;57:328,333-5.
13. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998;280:1566-7.
14. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ 1989;299:1156-7.
15. Hallam K, Oliver JS, McGrath C, Norman TR. Comparative cognitive and psychomotor effects of single does of Valeriana officinalis and triazolam in healthy volunteers. Hum Psychopharmacol 2003;18:619-25.
16. Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med 1985;51:144-8.
17. Valeriana officinalis (monograph). Altern Med Rev 2004;9:438-41.